Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 7 studies | 42% ± 16% | |
goblet cell | 6 studies | 22% ± 8% | |
epithelial cell of proximal tubule | 5 studies | 21% ± 4% | |
epithelial cell | 5 studies | 37% ± 14% | |
brush cell | 4 studies | 52% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 3 studies | 25% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 5844.07 | 89 / 89 | 71% | 224.49 | 636 / 901 |
intestine | 71% | 7505.89 | 690 / 966 | 94% | 171.20 | 497 / 527 |
stomach | 64% | 78.68 | 228 / 359 | 88% | 146.42 | 251 / 286 |
pancreas | 21% | 12.07 | 70 / 328 | 75% | 80.12 | 134 / 178 |
prostate | 73% | 431.14 | 180 / 245 | 22% | 17.64 | 108 / 502 |
esophagus | 37% | 140.90 | 538 / 1445 | 46% | 67.30 | 84 / 183 |
skin | 70% | 111.47 | 1264 / 1809 | 0% | 0 | 0 / 472 |
liver | 65% | 247.65 | 146 / 226 | 3% | 1.23 | 12 / 406 |
lung | 32% | 18.79 | 185 / 578 | 31% | 32.60 | 358 / 1155 |
peripheral blood | 52% | 147.64 | 483 / 929 | 0% | 0 | 0 / 0 |
bladder | 5% | 8.81 | 1 / 21 | 30% | 51.27 | 152 / 504 |
spleen | 35% | 22.51 | 84 / 241 | 0% | 0 | 0 / 0 |
ovary | 2% | 0.99 | 4 / 180 | 30% | 26.22 | 129 / 430 |
uterus | 6% | 9.01 | 10 / 170 | 18% | 25.01 | 82 / 459 |
heart | 21% | 10.88 | 177 / 861 | 0% | 0 | 0 / 0 |
thymus | 15% | 7.46 | 97 / 653 | 5% | 2.25 | 30 / 605 |
breast | 7% | 20.94 | 34 / 459 | 3% | 2.47 | 39 / 1118 |
adipose | 7% | 4.29 | 87 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 1% | 0.32 | 2 / 258 | 6% | 10.46 | 13 / 230 |
blood vessel | 4% | 1.65 | 49 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.16 | 3 / 803 | 0% | 0 | 0 / 0 |
brain | 0% | 0.06 | 3 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009445 | Biological process | putrescine metabolic process |
GO_0046677 | Biological process | response to antibiotic |
GO_0009308 | Biological process | amine metabolic process |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0035580 | Cellular component | specific granule lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005777 | Cellular component | peroxisome |
GO_0005923 | Cellular component | bicellular tight junction |
GO_0008201 | Molecular function | heparin binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0052597 | Molecular function | diamine oxidase activity |
GO_0052599 | Molecular function | methylputrescine oxidase activity |
GO_0008131 | Molecular function | primary amine oxidase activity |
GO_0050232 | Molecular function | putrescine oxidase activity |
GO_0052598 | Molecular function | histamine oxidase activity |
GO_0048038 | Molecular function | quinone binding |
GO_0052600 | Molecular function | propane-1,3-diamine oxidase activity |
GO_0005507 | Molecular function | copper ion binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | AOC1 |
Protein name | Amine oxidase (EC 1.4.3.-) Diamine oxidase [copper-containing] (Diamine oxidase) (EC 1.4.3.22) (Amiloride-binding protein) (Amiloride-binding protein 1) (Amine oxidase copper domain-containing protein 1) (Histaminase) (Kidney amine oxidase) (KAO) (KDAO) |
Synonyms | DAO ABP ABP1 |
Description | FUNCTION: Catalyzes the oxidative deamination of primary amines to the corresponding aldehydes with the concomitant production of hydrogen peroxide and ammonia . Its preferred substrates are the diamines histamine and 1-methylhistamine and it could therefore play a role in allergic and immune responses . Has a broad specificity for diamines and can also act on cadaverine and putrescine, two products of amino acid catabolism . It could also act on polyamines, like spermidine and spermine though less efficiently, and regulate various biological processes . . |
Accessions | ENST00000483043.1 ENST00000493429.5 [P19801-1] C9J0G8 C9J2J4 ENST00000467291.5 [P19801-1] P19801 ENST00000460213.1 ENST00000360937.9 [P19801-1] ENST00000416793.6 [P19801-2] |